Methodological considerations in the development of HPLC-MS methods for the analysis of rodent plasma for metabonomic studies†
Abstract
A study of the factors involved in obtaining valid global
Maintenance work is planned for Wednesday 5th April 2023 from 09:00 to 10:30 (BST).
During this time the performance of our website may be affected - searches may run slowly and some pages may be temporarily unavailable. If this happens, please try refreshing your web browser or try waiting two to three minutes before trying again. We apologise for any inconvenience caused and thank you for your patience.
* Corresponding authors
a
Dept of Drug Metabolism and Pharmacokinetics, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire, UK
E-mail:
ian.wilson@astrazeneca.com
Fax: 00 44 1625 516962
Tel: 00 44 1625 513424
b Laboratory of Analytical Chemistry, Aristotle University of Thessaloniki, Greece
c AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire, UK
d Applied Biosystems/MDS Analytical Technologies, Concord, ON, Canada
A study of the factors involved in obtaining valid global
L. Lai, F. Michopoulos, H. Gika, G. Theodoridis, R. W. Wilkinson, R. Odedra, J. Wingate, R. Bonner, S. Tate and I. D. Wilson, Mol. BioSyst., 2009, 6, 108 DOI: 10.1039/B910482H
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content